These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20619050)

  • 1. [Unequal discounting of health care costs and effects causes confusion].
    van Ballegooijen M; de Kok IM; Habbema JD
    Ned Tijdschr Geneeskd; 2010; 154():A1970. PubMed ID: 20619050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discounting in health care decision-making: time for a change?
    Sheldon TA
    J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discounting in economic evaluations: stepping forward towards optimal decision rules.
    Gravelle H; Brouwer W; Niessen L; Postma M; Rutten F
    Health Econ; 2007 Mar; 16(3):307-17. PubMed ID: 17006970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention, policy, and paradox: what is the value of future health?
    Ganiats TG
    Am J Prev Med; 1997; 13(1):12-7. PubMed ID: 9037337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines and costs].
    Casparie AF; van Hout BA; Simoons ML
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2075-7. PubMed ID: 9856218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discounting and risk characteristics in clinical decision-making.
    Ortendahl M; Fries JF
    Med Sci Monit; 2006 Mar; 12(3):RA41-5. PubMed ID: 16501432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [More care for a limited budget; a case for a better use of the efficiency criteria].
    Rutten FF; Brouwer WB
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foundations of cost-effectiveness analysis for health and medical practices.
    Weinstein MC; Stason WB
    N Engl J Med; 1977 Mar; 296(13):716-21. PubMed ID: 402576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framing health messages based on anomalies in time preference.
    Ortendahl M; Fries JF
    Med Sci Monit; 2005 Aug; 11(8):RA253-6. PubMed ID: 16049392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward targeted hypertension screening guidelines.
    van Buuren S; Boshuizen HC; Reijneveld SA
    Med Decis Making; 2006; 26(2):145-53. PubMed ID: 16525168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
    Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determining the possibility of collecting reliable data for use in decision making in health care on the example of cost-effectiveness analysis of methods used in smoking cessation].
    Bała M
    Przegl Lek; 2004; 61(10):1180-3. PubMed ID: 15794284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of an active implementation strategy for the Dutch physiotherapy guideline for low back pain.
    Hoeijenbos M; Bekkering T; Lamers L; Hendriks E; van Tulder M; Koopmanschap M
    Health Policy; 2005 Dec; 75(1):85-98. PubMed ID: 16298231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.
    Postma MJ; van Hulst M; De Wolf JT; Botteman M; Staginnus U
    Transfus Med; 2005 Oct; 15(5):379-87. PubMed ID: 16202052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.